Results 71 to 80 of about 43,240 (162)
Safety of upadacitinib in atopic dermatitis in randomized clinical trials across 6 years
The current study found no evidence of cumulative increased safety risks with upadacitinib 15 or 30 mg for up to 6 years and over 9000 patient‐years of safety data in adults and adolescents. There were low rates of adjudicated major adverse cardiovascular events, adjudicated thromboembolic events and malignancies. Abstract Background Atopic dermatitis (
Christopher G. Bunick +13 more
wiley +1 more source
Serum Levels and Genetic Variants of CC16: Associations With Asthma and Lung Function Development
Clinical &Experimental Allergy, EarlyView.
Hans Jacob L. Koefoed +7 more
wiley +1 more source
Achieving rapid control of itch in atopic dermatitis and prurigo nodularis may minimize symptomatology and disease burden. Analysis of clinical trials in atopic dermatitis and prurigo nodularis showed significantly more patients in nemolizumab versus placebo groups achieved a meaningful clinical response in itch within 48 h, and separation increased ...
Sonja Ständer +10 more
wiley +1 more source
En este artículo el autor propone y expone una hermenéutica del cine destinada a descubrir en la secuencia fílmica, contenidos subliminales que mediante analogías, remiten a un modelo narrativo diferente o asociado al modelo aparente de una cinta ...
Gastón Soublette Amussen
doaj
Por qué el conflicto. Cara a cara entre Simmel y Galtung: convergencias y disputas
Introducción: El artículo pretende una nueva conceptualización de conflicto comparando las posturas de sus pioneros, Georg Simmel y Johan Galtung. Tras ambos hemos aprendido que la paz está relacionada con la violencia y que esta última es un conflicto ...
Tiziano Telleschi
doaj +1 more source
Nemolizumab in prurigo nodularis up to 100 weeks: OLYMPIA LTE interim analysis
In this interim analysis of the OLYMPIA long‐term extension trial, nemolizumab exhibited sustained efficacy and was well tolerated through 100 weeks, with most adverse events being mild/moderate. Patients showed clinically meaningful improvements in core signs and symptoms.
Franz J. Legat +22 more
wiley +1 more source
This scoping study refined the first patient‐centred outcome set for psoriasis, involving patient representatives and dermatologists from 22 countries. The proposal includes 18 patient‐relevant outcomes, 2 patient experiences, corresponding outcome measurement instruments and 50 case‐mix variables.
Emma Vyvey +35 more
wiley +1 more source

